Dinner Innovation Theater (Non-Accredited): Leading With a VMAT2 Inhibitor for Patients With Tardive Dyskinesia

Dinner will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs. Presenters: Hara Oyedeji, DNP, PMHNP-BC, MSEd; Laura K. Melaro, DNP, APRN, FNP-BC, PMHNP-BC This presentation is provided by Neurocrine Biosciences, Inc.